Identification of a novel PRMD16::SKI fusion gene in T-prolymphocytic leukemia
The presence of the <i>PRDM16::SKI</i> fusion gene was described, for the first time, in a T prolymphocytic leukemia (T-PLL) patient with a long indolent period and a late development treatment requiring disease. The fusion transcript was detected by RNA sequencing and validated by reverse transcriptase polymerase chain reaction and Sanger/Cycle sequencing. The chimera occurs between exon 1 of the PR/SET Domain 16 (<i>PRDM16</i>) gene and exon 2 of the oncogene V-Ski Avian Sarcoma Viral Oncogene Homolog (<i>SKI</i>) gene. The finding provides insight into the role of genetic alterations, including fusion genes, in development and progression of T-PLL and may possibly lead to the development of effective and precise targeted therapy for this disease.
Authors
- Francesca Micci (ORCID: https://orcid.org/0000-0002-2194-556X)
- Håkon Reikvam (ORCID: https://orcid.org/0000-0001-5439-8411)
- Hilde Kollsete Gjelberg
- Marta Brunetti (ORCID: https://orcid.org/0000-0002-0150-2067)
Institutions
- Haukeland University Hospital (NO)
- Norwegian Cancer Society (NO)
- University of Bergen (NO)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-08-26
- DOI
- https://doi.org/10.3389/fonc.2025.1658257
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00